Applying PET to Broaden the Diagnostic Utility of the Clinically Validated CA19.9 Serum Biomarker for Oncology

Despite their considerable advantages, many circulating biomarkers have well-documented limitations. One prominent shortcoming in oncology is a high frequency of false-positive indications for malignant disease in upfront diagnosis. Because one common cause of false positivism is biomarker productio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Nucl Med
Main Authors: Viola-Villegas, Nerissa Therese, Rice, Samuel L., Carlin, Sean, Wu, Xiaohong, Evans, Michael J., Sevak, Kuntal K., Drobjnak, Marija, Ragupathi, Govind, Sawada, Ritsuko, Scholz, Wolfgang W., Livingston, Philip O., Lewis, Jason S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4274751/
https://ncbi.nlm.nih.gov/pubmed/24029655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.113.119867
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados